Leflunomide for Chronic Sarcoidosis

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 21, Issue 1, 2004, Pages 43-48

  Baughman, Robert P ^a,b   Lower, Elyse E ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b 1001 Homes ^*  (United States)

Author keywords

Methotrexate; Ocular Sarcoidosis; Prednisone; Pulmonary Sarcoidosis

Indexed keywords

LEFLUNOMIDE; METHOTREXATE;

ADULT; ADVERSE DRUG REACTION; AGED; CHRONIC DISEASE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG RESPONSE; DRUG TOLERABILITY; DRUG USE; EYE DISEASE; FEMALE; HUMAN; LUNG SARCOIDOSIS; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NAUSEA; PRIORITY JOURNAL; REVIEW; SARCOIDOSIS; UNITED STATES;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHRONIC DISEASE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISOXAZOLES; MALE; METHOTREXATE; MIDDLE AGED; NAUSEA; RETROSPECTIVE STUDIES; SARCOIDOSIS; TREATMENT OUTCOME;

EID: 2042514951     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Baughman RP, Lower EE: A clinical approach to the use of methotrexate for sarcoidosis. Thorax 1999; 54: 742-6.
2. Baughman RP, Winget DB, Lower EE: Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial. Sarcoidosis 2000; 17: 60-6.
3. Lower EE, Broderick JP, Brott TG, Baughman RP: Diagnosis and management of neurologic sarcoidosis. Arch Intern Med 1997; 157: 1864-8.
4. Lower EE, Baughman RP: Prolonged use of methotrexate for sarcoidosis. Arch Intern Med 1995; 155: 846-51.
5. Zisman DA, McCune WJ, Tino G, Lynch JP: III. Drug-induced pneumonitis: the role of methotrexate. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18: 243-52.
6. Kremer JM, Alarcon GS, Weinblatt ME, et al: Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review. Arthritis Rheum 1997; 40: 1829-37.
7. Baughman RP, Koehler A, Bejarano PA, Lower EE, Weber FL Jr: Role of liver function tests in detecting methotrexate-induced liver damage in sarcoidosis. Arch Intern Med 2003; 163: 615-20.
8. Fox RI, Herrmann ML, Frangou CG, et al: Mechanism of action for leflunomide in rheumatoid arthritis. Clin Immunol 1999; 93: 198-208.
9. Cohen S, Cannon GW, Schiff M, et al: Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group. Arthritis Rheum 2001; 44: 1984-92.
10. Emery P, Breedveld FC, Lemmel EM, et al: A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis. Rheumatology (Oxford) 2000; 39: 655-65.
11. Osiri M, Shea B, Robinson V, et al: Leflunomide for the treatment of rheumatoid arthritis: a systematic review and metaanalysis. J Rheumatol 2003; 30: 1182-90.
12. Kremer JM: Methotrexate and leflunomide: biochemical basis for combination therapy in the treatment of rheumatoid arthritis. Semin Arthritis Rheum 1999; 29: 14-26.
13. Kremer JM, Caldwell JR, Cannon GW, et al: The combination of leflunomide and methotrexate in patients with active rheumatoid arthritis who are failing on methotrexate treatment alone: a double-blind placebo controlled study. Arthritis Rheum 2000; 43: S224.
14. Judson MA, Baughman RP, Teirstein AS, Terrin ML, Yeager H Jr, the ACCESS Research group: Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 75-86.
15. Hunninghake GW, Costabel U, Ando M, et al: ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 149-73.
16. Osiri M, Shea B, Robinson V, et al: Leflunomide for treating rheumatoid arthritis. Cochrane Database Syst Rev 2003; CD002047.
17. Majithia V, Sanders S, Harisdangkul V, Wilson JG: Successful treatment of sarcoidosis with leflunomide. Rheumatology (Oxford) 2003; 42: 700-2.
18. Gedalia A, Molina JF, Ellis GS, Galen W, Moore C, Espinoza LR: Low-dose methotrexate therapy for childhood sarcoidosis. J Pediatr 1997; 130: 25-9.
19. Vucinic VM: What is the future of methotrexate in sarcoidosis? A study and review. Curr Opin Pulm Med 2002; 8: 470-6.
20. Baughman RP, Winget DB, Lower EE: Prospective, randomized, double blind trial of methotrexate as a steroid sparing agent for sarcoidosis: analysis of first 25 patients. Am J Respir Crit Care Med 1997; 155: A944.
21. Baughman RP, Lower EE: The effect of corticosteroid or methotrexate therapy on lung lymphocytes and macrophages in sarcoidosis. Am Rev Respir Dis 1990; 142: 1268-71.
22. Ziegenhagen MW, Rothe E, Zissel G, Muller-Quemheim J: Exaggerated TNFalpha release of alveolar macrophages in corticosteroid resistent sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19: 185-90.
23. Baughman R, Lower EE: Can persistent tumor necrosis factor release lead to refractory sarcoidosis? Sarcoidosis Vasc Diffuse Lung Dis 2002; 19: 164-6.
24. Scott DL, Smolen JS, Kalden JR, et al: Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine. Ann Rheum Dis 2001; 60: 913-23.
25. Legras A, Bergemer-Fouquet AM, Jonville-Bera AP: Fatal hepatitis with leflunomide and itraconazole. Am J Med 2002; 113: 352-3.
26. Weinblatt ME, Dixon JA, Falchuk KR: Serious liver disease in a patient receiving methotrexate and leflunomide. Arthritis Rheum 2000; 43: 2609-11.
27. White DA, Rankin JA, Stover DE, Gellene RA, Gupta S: Methotrexate pneumonitis: bronchoalveolar lavage findings suggest an immunologic disorder. Am Rev Respir Dis 1989; 139: 18-21.
28. Kremer JM, Genovese MC, Cannon GW, et al: Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2002; 137: 726-33.
29. Baughman RP, Ohmichi M, Lower EE: Combination therapy for sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18: 133-7.
30. Samson CM, Waheed N, Baltatzis S, Foster CS: Methotrexate therapy for chronic non-infectious uveitis: analysis of a case series of 160 patients. Ophthalmology 2001; 108: 1134-9.
31. Dev S, McCallum RM, Jaffe GJ: Methotrexate for sarcoid-associated panuveitis. Ophthalmology 1999; 106: 111-18.
32. Bradley DA, Baughman RP, Raymond L, Kaufman AH: Ocular manifestations of sarcoidosis. Semin Resp Crit Care Med 2002; 23: 543-8.
33. Baughman RP, Lower EE, Bradley DA, Kaufman AH: Use of cytotoxic therapy for chronic ophthalmic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: S 17.